Table 4 Demographical and clinical characteristics of the enrolled subjects for the IP-10 study

Hospitalized N (%)

15 (100)

0 (0)

0 (0)

–

Enrolled “X” days after symptoms onset

14-Jan

35–100

/

–

Age median (IQR)

63 (52–70)

55 (31–60)

44 (38–53)

< 0.0001*

Male N (%)

11 (73)

0 (0)

13 (68)

0.0008^§

Origin N (%)

 West Europe

15 (100)

9 (90)

18 (100)

0.208^§

 East Europe

0 (0)

1 (10)

0

 Asia

0 (0)

0 (0)

0

Swab positive results N (%)

14 (93)

5 (50)

0 (0)

0.0036^§§

Serology results IgM N (%)^a

 IgM +

10 (66.7)

2 (22.2)

0 (0)

 IgM −

4 (26.6)

5 (55.6)

0 (0)

0.2999^§§

 IgM doubtful

1 (6.7)

2 (22.2)

0 (0)

Serology results IgG N (%)^a

 IgG +

12 (80)

8 (88.9)

0 (0)

 IgG −

2 (13.3)

1 (11.1)

0 (0)

0.820^§§

 IgG doubtful

1 (6.7)

0 (0)

0 (0)

Severity N (%)#

 Mild

0 (0)

9 (90)

/

 Moderate

4 (26.7)

0 (0)

/

< 0.0001^§§

 Severe

8 (53.3)

1 (10)

/

 Critical

3 (20)

0 (0)

/